Manufacturers Life Insurance Company, The Ab Cellera Biologics Inc. Transaction History

Manufacturers Life Insurance Company, The

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$5.66 - $7.59 $430,624 - $577,462	-76,082 Closed	0 $0
Q4 2022 Aug 11, 2023	BUY	$9.48 - $14.52 $711 - $1,089	75 Added 0.1%	76,082 $770,000
Q4 2022 Feb 13, 2023	BUY	$9.48 - $14.52 $711 - $1,089	75 Added 0.1%	76,082 $770,000
Q3 2022 Aug 11, 2023	SELL	$9.2 - $13.68 $12,797 - $19,028	-1,391 Reduced 1.8%	76,007 $751,000
Q3 2022 Nov 03, 2022	SELL	$9.2 - $13.68 $12,797 - $19,028	-1,391 Reduced 1.8%	76,007 $752,000
Q2 2022 Aug 11, 2023	BUY	$5.72 - $10.65 $7,527 - $14,015	1,316 Added 1.73%	77,398 $824,000
Q2 2022 Aug 15, 2022	BUY	$5.72 - $10.65 $442,716 - $824,288	77,398 New	77,398 $824,000

154

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $841M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.